GNI Group Ltd.
GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also …
Biotechnology
JP, Tokyo [HQ]
2160.T/Financial Reporting
Income Statements
14 Sheets · Starting from 2010In Million JPY. Margins, Growth Rates In %
| Metric | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 272.00 | 90.00 | 161.00 | 183.00 | 474.00 | 1,016.00 | 1,306.00 | 2,648.00 | 5,018.00 | 7,446.00 | 9,773.00 | 12,690.00 | 17,418.00 | 26,010.00 | |
|
EPS
|
-9.61 | -16.07 | -16.15 | -23.85 | -9.71 | -18.29 | -15.03 | -4.66 | 4.74 | 14.91 | 28.96 | 1.18 | -18.29 | 169.50 | |
| Diluted in mil. | -9.61 | -16.07 | -16.15 | -23.85 | -9.47 | -17.87 | -15.03 | -4.66 | 4.74 | 14.45 | 28.04 | 1.14 | -18.11 | 165.56 | |
|
Profit
|
211.00 | 17.00 | 34.00 | 17.00 | 313.00 | 775.00 | 1,117.00 | 2,153.00 | 4,170.00 | 6,395.00 | 8,227.00 | 11,089.00 | 14,744.00 | 22,431.00 | |
| Gross Margin | 77.33 | 19.81 | 21.37 | 9.39 | 66.05 | 76.30 | 85.49 | 81.31 | 83.10 | 85.89 | 84.18 | 87.39 | 84.65 | 86.24 | |
| Pre Tax | -256.00 | -459.00 | -544.00 | -785.00 | -294.00 | -669.00 | -385.00 | 137.00 | 364.00 | 1,197.00 | 1,805.00 | 1,107.00 | 767.00 | 12,612.00 | |
| Profit Margin | -94.14 | -508.30 | -336.36 | -428.03 | -62.02 | -65.86 | -29.49 | 5.18 | 7.27 | 16.08 | 18.48 | 8.72 | 4.41 | 48.49 | |
| ETR | -0.47 | -0.26 | -0.22 | -5.88 | -0.72 | 0.16 | -20.84 | 79.43 | 47.31 | 47.40 | 24.36 | 95.01 | 213.07 | 24.65 | |
| Net | -258.00 | -435.00 | -482.00 | -730.00 | -327.00 | -623.00 | -513.00 | -175.00 | 192.00 | 629.00 | 1,258.00 | 55.00 | -868.00 | 8,094.00 | |
| Profit Margin | -94.58 | -482.06 | -297.79 | -398.03 | -69.08 | -61.29 | -39.26 | -6.62 | 3.83 | 8.46 | 12.87 | 0.44 | -4.98 | 31.12 | |
| EBITDA | -154.00 | -364.00 | -375.00 | -735.00 | -386.00 | -564.00 | -191.00 | 261.00 | 744.00 | 1,578.00 | 2,245.00 | 2,137.00 | 2,159.00 | 5,188.00 | |
| EBITDA Margin | -56.54 | -403.20 | -231.94 | -400.84 | -81.35 | -55.49 | -14.63 | 9.86 | 14.83 | 21.20 | 22.97 | 16.85 | 12.40 | 19.95 | |
| Operating Income | -269.00 | -457.00 | -464.00 | -785.00 | -550.00 | -633.00 | -276.00 | 154.00 | 568.00 | 1,302.00 | 1,869.00 | 1,624.00 | 1,377.00 | 4,580.00 | |
| Operating Margin | -98.59 | -506.24 | -286.87 | -427.64 | -116.00 | -62.28 | -21.15 | 5.82 | 11.33 | 17.49 | 19.13 | 12.80 | 7.91 | 17.61 | |
| Interest Income | - - | - - | - - | 1.00 | 5.00 | 27.00 | 19.00 | 51.00 | 21.00 | 39.00 | 46.00 | 129.00 | 259.00 | 771.00 | |
| Loss | -541.00 | -547.00 | -626.00 | -968.00 | -1,025.00 | -1,649.00 | -1,583.00 | -2,494.00 | -4,450.00 | -6,143.00 | -7,904.00 | -11,065.00 | -16,041.00 | -21,430.00 | |
| Cost of Revenue | -61.00 | -72.00 | -127.00 | -166.00 | -161.00 | -240.00 | -189.00 | -494.00 | -848.00 | -1,050.00 | -1,545.00 | -1,600.00 | -2,674.00 | -3,579.00 | |
|
Operating Expenses
|
-480.00 | -475.00 | -499.00 | -802.00 | -864.00 | -1,408.00 | -1,393.00 | -1,999.00 | -3,602.00 | -5,092.00 | -6,358.00 | -9,464.00 | -13,366.00 | -17,850.00 | |
| R&D | - - | - - | -101.00 | -427.00 | -139.00 | -379.00 | -274.00 | -268.00 | -530.00 | -758.00 | -1,243.00 | -2,015.00 | -2,545.00 | -2,557.00 | |
| G&A | - - | - - | - - | - - | - - | -1,049.00 | -1,118.00 | -1,740.00 | -2,998.00 | -4,334.00 | -5,180.00 | -7,958.00 | -10,965.00 | -15,292.00 | |
| SG&A | - - | - - | -331.00 | -367.00 | -715.00 | -1,049.00 | -1,118.00 | -1,740.00 | -2,998.00 | -4,334.00 | -5,180.00 | -7,958.00 | -10,965.00 | -15,292.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -2,654.00 | -3,632.00 | - - | |
| Depreciation and Amortization | -121.00 | -97.00 | -99.00 | -36.00 | -43.00 | -61.00 | -65.00 | -89.00 | -153.00 | -236.00 | -329.00 | -383.00 | -521.00 | -608.00 | |
| Interest Expenses | -18.00 | -1.00 | -9.00 | -9.00 | -11.00 | -44.00 | -128.00 | -34.00 | -225.00 | -144.00 | -109.00 | -647.00 | -869.00 | -1,250.00 | |
| Other Expenses | -12.00 | -1.00 | -80.00 | - - | -256.00 | -36.00 | -109.00 | -17.00 | -203.00 | -104.00 | -63.00 | -517.00 | -610.00 | -8,032.00 | |
|
WA Shares Outstanding
|
26.00 | 27.00 | 29.00 | 30.00 | 33.00 | 34.00 | 34.00 | 37.00 | 40.00 | 42.00 | 43.00 | 46.00 | 47.00 | 47.00 | |
| Diluted | 26.00 | 27.00 | 29.00 | 30.00 | 34.00 | 34.00 | 34.00 | 37.00 | 40.00 | 43.00 | 44.00 | 48.00 | 47.00 | 48.00 |